Atlanta Consulting Group Advisors LLC Takes Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Atlanta Consulting Group Advisors LLC acquired a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 1,028 shares of the medical equipment provider's stock, valued at approximately $505,000.

Several other large investors have also recently bought and sold shares of the stock. Hazlett Burt & Watson Inc. increased its stake in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider's stock valued at $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. increased its stake in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider's stock valued at $247,000 after buying an additional 20 shares during the period. Ullmann Wealth Partners Group LLC increased its stake in Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider's stock valued at $653,000 after buying an additional 21 shares during the period. One Wealth Management Investment & Advisory Services LLC boosted its position in shares of Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider's stock valued at $310,000 after purchasing an additional 23 shares in the last quarter. Finally, Falcon Wealth Planning boosted its holdings in shares of Intuitive Surgical by 0.4% in the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider's stock worth $2,797,000 after buying an additional 23 shares during the period. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG traded up $4.03 on Monday, hitting $531.64. The stock had a trading volume of 1,268,011 shares, compared to its average volume of 1,460,418. Intuitive Surgical, Inc. has a twelve month low of $304.50 and a twelve month high of $544.38. The firm's 50 day moving average price is $499.29 and its 200-day moving average price is $458.50. The company has a market capitalization of $189.36 billion, a price-to-earnings ratio of 84.82, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. Leerink Partners raised their price target on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Oppenheimer reaffirmed a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Evercore ISI reaffirmed a "cautious" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Redburn Atlantic raised shares of Intuitive Surgical from a "neutral" rating to a "buy" rating and raised their price objective for the company from $380.00 to $510.00 in a research report on Friday, August 2nd. Finally, Piper Sandler reaffirmed an "overweight" rating and set a $538.00 price objective (up previously from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and thirteen have issued a buy rating to the company's stock. According to MarketBeat.com, Intuitive Surgical has an average rating of "Moderate Buy" and a consensus target price of $524.61.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 396 shares of the business's stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $486.88, for a total transaction of $192,804.48. Following the completion of the sale, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,680,761.28. The trade was a 6.71 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jamie Samath sold 269 shares of the business's stock in a transaction dated Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the sale, the insider now directly owns 8,757 shares of the company's stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 91,178 shares of company stock valued at $45,897,071 over the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.